|
1
|
Kohl NE, Kanda N, Schreck RR, Bruns G,
Latt SA, Gilbert F and Alt FW: Transposition and amplification of
oncogene-related sequences in human neuroblastomas. Cell.
35:359–367. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kohl NE, Legouy E, DePinho RA, Nisen PD,
Smith RK, Gee CE and Alt FW: Human N-myc is closely related in
organization and nucleotide sequence to c-myc. Nature. 319:73–77.
1986. View
Article : Google Scholar
|
|
3
|
Cohn SL, Pearson AD, London WB, Monclair
T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, et
al: The international neuroblastoma risk group (INRG)
classification system: An INRG task force report. J Clin Oncol.
27:289–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang M and Weiss WA: Neuroblastoma and
MYCN. Cold Spring Harb Perspect Med. 3(a014415)2013.PubMed/NCBI
|
|
5
|
Brodeur GM, Seeger RC, Schwab M, Varmus HE
and Bishop JM: Amplification of N-myc in untreated human
neuroblastomas correlates with advanced disease stage. Science.
224:1121–1124. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gatcombe HG, Marcus RB Jr, Katzenstein HM,
Tighiouart M and Esiashvili N: Excellent local control from
radiation therapy for high-risk neuroblastoma. Int J Radiat Oncol
Biol Phys. 74:1549–1554. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morgan MA and Lawrence TS: Molecular
pathways: Overcoming radiation resistance by targeting DNA damage
response pathways. Clin Cancer Res. 21:2898–2904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Preter K, Speleman F, Combaret V, Lunec
J, Laureys G, Eussen BH, Francotte N, Board J, Pearson AD, De Paepe
A, et al: Quantification of MYCN, DDX1, and NAG gene copy number in
neuroblastoma using a real-time quantitative PCR assay. Mod Pathol.
15:159–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schweigerer L, Breit S, Wenzel A,
Tsunamoto K, Ludwig R and Schwab M: Augmented MYCN expression
advances the malignant phenotype of human neuroblastoma cells:
Evidence for induction of autocrine growth factor activity. Cancer
Res. 50:4411–4416. 1990.PubMed/NCBI
|
|
11
|
Maier P, Hartmann L, Wenz F and Herskind
C: Cellular Pathways in Response to Ionizing Radiation and Their
Targetability for Tumor Radiosensitization. Int J Mol Sci.
17:1022016. View Article : Google Scholar
|
|
12
|
Malynn BA, de Alboran IM, O'Hagan RC,
Bronson R, Davidson L, DePinho RA and Alt FW: N-myc can
functionally replace c-myc in murine development, cellular growth,
and differentiation. Genes Dev. 14:1390–1399. 2000.PubMed/NCBI
|
|
13
|
Stanton BR, Perkins AS, Tessarollo L,
Sassoon DA and Parada LF: Loss of N-myc function results in
embryonic lethality and failure of the epithelial component of the
embryo to develop. Genes Dev. 6:2235–2247. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Breit S and Schwab M: Suppression of MYC
by high expression of NMYC in human neuroblastoma cells. J Neurosci
Res. 24:21–28. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruzinova MB, Caron T and Rodig SJ: Altered
subcellular localization of c-myc protein identifies aggressive
B-cell lymphomas harboring a c-MYC translocation. Am J Surg Pathol.
34:882–891. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dang CV and Lee WM: Identification of the
human c-myc protein nuclear translocation signal. Mol Cell Biol.
8:4048–4054. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soldani C, Bottone MG, Biggiogera M,
Alpini C, Scovassi AI, Martin T and Pellicciari C: Nuclear
localization of phosphorylated c-myc protein in human tumor cells.
Eur J Histochem. 46:377–380. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith KP, Byron M, O'Connell BC, Tam R,
Schorl C, Guney I, Hall LL, Agrawal P, Sedivy JM and Lawrence JB:
C-myc localization within the nucleus: Evidence for association
with the PML nuclear body. J Cell Biochem. 93:1282–1296. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meitar D, Crawford SE, Rademaker AW and
Cohn SL: Tumor angiogenesis correlates with metastatic disease,
N-myc amplification, and poor outcome in human neuroblastoma. J
Clin Oncol. 14:405–414. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edry Botzer L, Maman S, Sagi-Assif O,
Meshel T, Nevo I, Bäuerle T, Yron I and Witz IP: Lung-residing
metastatic and dormant neuroblastoma cells. Am J Pathol.
179:524–536. 2011. View Article : Google Scholar : PubMed/NCBI
|
